The divergence comes just as Injective kicks off its new Community Buy-Back program.Finance, Injective, Injective Labs, TVL, token, Market Cap, NewsRead More

You might also be interested in reading Hedera’s (HBAR) $0.09 Support Intact, Revenue Decline Threatens Upside Momentum.